I did say that the recruitment of two additional patients for screening was good news
I also liked the statement that ppl-1 appears safe and no adverse events have been observed
DYOR
Ann: Second Patient In Human Cancer Trial Begins Treatment, page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $114.3M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $218.0K | 921.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 404461 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 6664 | 2 |
View Market Depth
| Last trade - 15.15pm 15/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |